Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer

Steven B. Zeliadt, David F. Penson, Carol M. Moinpour, David K. Blough, Catherine R. Fedorenko, Ingrid J. Hall, Judith Lee Smith, Donatus U. Ekwueme, Ian M. Thompson, Thomas E. Keane, Scott D. Ramsey

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

OBJECTIVE To evaluate the degree to which the partners of prostate cancer patients participate in the shared decision-making process with the patients' providers during the time between diagnosis and initiating treatment. PATIENTS AND METHODS We recruited patients with newly diagnosed local-stage prostate cancer and their partners to complete take-home surveys after biopsy but before initiating treatment at urology practices in three states. We asked partners to describe their roles in the decision-making process, including participation in clinic visits, and perceptions of encouragement from providers to participate in the treatment decision-making process. We also asked partners to rate their satisfaction with the patients' providers. RESULTS Family members of 80% of newly diagnosed patients agreed to participate; most (93%) were partners (i.e. spouses or significant others). Most partners (93%) had direct contact with the patients' physicians. Among the partners who had contact with providers, most (67%) were very satisfied with the patients' providers and 80% indicated that the doctor encouraged them to participate in the treatment decision. Overall, 91% of partners reported very frequent discussions with their loved one about the pending treatment decision, and 69% reported that their role was to help the patient make a decision. In multivariate models, provider encouragement of partner participation was associated with higher partner satisfaction (odds ratio 3.4, 95% CI 1.4-8.4) and an increased likelihood of partners reporting very frequent discussions with their loved one (odds ratio 6.1, 95% CI 1.3-27.7). CONCLUSIONS Partners often attended clinic visits and were very involved in discussions about treatment options with both loved ones and providers. Provider encouragement of participation by partners greatly facilitates shared decision-making between patients and partners.

Original languageEnglish (US)
Pages (from-to)851-856
Number of pages6
JournalBJU International
Volume108
Issue number6
DOIs
StatePublished - Sep 2011

Fingerprint

Prostatic Neoplasms
Decision Making
Therapeutics
Ambulatory Care
Odds Ratio
Urology
Patient Satisfaction
Spouses
Physicians
Biopsy

Keywords

  • family member involvement
  • patient-provider communication
  • prostate cancer
  • provider-partner communication
  • shared decision-making

ASJC Scopus subject areas

  • Urology

Cite this

Zeliadt, S. B., Penson, D. F., Moinpour, C. M., Blough, D. K., Fedorenko, C. R., Hall, I. J., ... Ramsey, S. D. (2011). Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer. BJU International, 108(6), 851-856. https://doi.org/10.1111/j.1464-410X.2010.09945.x

Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer. / Zeliadt, Steven B.; Penson, David F.; Moinpour, Carol M.; Blough, David K.; Fedorenko, Catherine R.; Hall, Ingrid J.; Smith, Judith Lee; Ekwueme, Donatus U.; Thompson, Ian M.; Keane, Thomas E.; Ramsey, Scott D.

In: BJU International, Vol. 108, No. 6, 09.2011, p. 851-856.

Research output: Contribution to journalArticle

Zeliadt, SB, Penson, DF, Moinpour, CM, Blough, DK, Fedorenko, CR, Hall, IJ, Smith, JL, Ekwueme, DU, Thompson, IM, Keane, TE & Ramsey, SD 2011, 'Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer', BJU International, vol. 108, no. 6, pp. 851-856. https://doi.org/10.1111/j.1464-410X.2010.09945.x
Zeliadt, Steven B. ; Penson, David F. ; Moinpour, Carol M. ; Blough, David K. ; Fedorenko, Catherine R. ; Hall, Ingrid J. ; Smith, Judith Lee ; Ekwueme, Donatus U. ; Thompson, Ian M. ; Keane, Thomas E. ; Ramsey, Scott D. / Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer. In: BJU International. 2011 ; Vol. 108, No. 6. pp. 851-856.
@article{f9d8e06464d14e2b91d29030d00fef43,
title = "Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer",
abstract = "OBJECTIVE To evaluate the degree to which the partners of prostate cancer patients participate in the shared decision-making process with the patients' providers during the time between diagnosis and initiating treatment. PATIENTS AND METHODS We recruited patients with newly diagnosed local-stage prostate cancer and their partners to complete take-home surveys after biopsy but before initiating treatment at urology practices in three states. We asked partners to describe their roles in the decision-making process, including participation in clinic visits, and perceptions of encouragement from providers to participate in the treatment decision-making process. We also asked partners to rate their satisfaction with the patients' providers. RESULTS Family members of 80{\%} of newly diagnosed patients agreed to participate; most (93{\%}) were partners (i.e. spouses or significant others). Most partners (93{\%}) had direct contact with the patients' physicians. Among the partners who had contact with providers, most (67{\%}) were very satisfied with the patients' providers and 80{\%} indicated that the doctor encouraged them to participate in the treatment decision. Overall, 91{\%} of partners reported very frequent discussions with their loved one about the pending treatment decision, and 69{\%} reported that their role was to help the patient make a decision. In multivariate models, provider encouragement of partner participation was associated with higher partner satisfaction (odds ratio 3.4, 95{\%} CI 1.4-8.4) and an increased likelihood of partners reporting very frequent discussions with their loved one (odds ratio 6.1, 95{\%} CI 1.3-27.7). CONCLUSIONS Partners often attended clinic visits and were very involved in discussions about treatment options with both loved ones and providers. Provider encouragement of participation by partners greatly facilitates shared decision-making between patients and partners.",
keywords = "family member involvement, patient-provider communication, prostate cancer, provider-partner communication, shared decision-making",
author = "Zeliadt, {Steven B.} and Penson, {David F.} and Moinpour, {Carol M.} and Blough, {David K.} and Fedorenko, {Catherine R.} and Hall, {Ingrid J.} and Smith, {Judith Lee} and Ekwueme, {Donatus U.} and Thompson, {Ian M.} and Keane, {Thomas E.} and Ramsey, {Scott D.}",
year = "2011",
month = "9",
doi = "10.1111/j.1464-410X.2010.09945.x",
language = "English (US)",
volume = "108",
pages = "851--856",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer

AU - Zeliadt, Steven B.

AU - Penson, David F.

AU - Moinpour, Carol M.

AU - Blough, David K.

AU - Fedorenko, Catherine R.

AU - Hall, Ingrid J.

AU - Smith, Judith Lee

AU - Ekwueme, Donatus U.

AU - Thompson, Ian M.

AU - Keane, Thomas E.

AU - Ramsey, Scott D.

PY - 2011/9

Y1 - 2011/9

N2 - OBJECTIVE To evaluate the degree to which the partners of prostate cancer patients participate in the shared decision-making process with the patients' providers during the time between diagnosis and initiating treatment. PATIENTS AND METHODS We recruited patients with newly diagnosed local-stage prostate cancer and their partners to complete take-home surveys after biopsy but before initiating treatment at urology practices in three states. We asked partners to describe their roles in the decision-making process, including participation in clinic visits, and perceptions of encouragement from providers to participate in the treatment decision-making process. We also asked partners to rate their satisfaction with the patients' providers. RESULTS Family members of 80% of newly diagnosed patients agreed to participate; most (93%) were partners (i.e. spouses or significant others). Most partners (93%) had direct contact with the patients' physicians. Among the partners who had contact with providers, most (67%) were very satisfied with the patients' providers and 80% indicated that the doctor encouraged them to participate in the treatment decision. Overall, 91% of partners reported very frequent discussions with their loved one about the pending treatment decision, and 69% reported that their role was to help the patient make a decision. In multivariate models, provider encouragement of partner participation was associated with higher partner satisfaction (odds ratio 3.4, 95% CI 1.4-8.4) and an increased likelihood of partners reporting very frequent discussions with their loved one (odds ratio 6.1, 95% CI 1.3-27.7). CONCLUSIONS Partners often attended clinic visits and were very involved in discussions about treatment options with both loved ones and providers. Provider encouragement of participation by partners greatly facilitates shared decision-making between patients and partners.

AB - OBJECTIVE To evaluate the degree to which the partners of prostate cancer patients participate in the shared decision-making process with the patients' providers during the time between diagnosis and initiating treatment. PATIENTS AND METHODS We recruited patients with newly diagnosed local-stage prostate cancer and their partners to complete take-home surveys after biopsy but before initiating treatment at urology practices in three states. We asked partners to describe their roles in the decision-making process, including participation in clinic visits, and perceptions of encouragement from providers to participate in the treatment decision-making process. We also asked partners to rate their satisfaction with the patients' providers. RESULTS Family members of 80% of newly diagnosed patients agreed to participate; most (93%) were partners (i.e. spouses or significant others). Most partners (93%) had direct contact with the patients' physicians. Among the partners who had contact with providers, most (67%) were very satisfied with the patients' providers and 80% indicated that the doctor encouraged them to participate in the treatment decision. Overall, 91% of partners reported very frequent discussions with their loved one about the pending treatment decision, and 69% reported that their role was to help the patient make a decision. In multivariate models, provider encouragement of partner participation was associated with higher partner satisfaction (odds ratio 3.4, 95% CI 1.4-8.4) and an increased likelihood of partners reporting very frequent discussions with their loved one (odds ratio 6.1, 95% CI 1.3-27.7). CONCLUSIONS Partners often attended clinic visits and were very involved in discussions about treatment options with both loved ones and providers. Provider encouragement of participation by partners greatly facilitates shared decision-making between patients and partners.

KW - family member involvement

KW - patient-provider communication

KW - prostate cancer

KW - provider-partner communication

KW - shared decision-making

UR - http://www.scopus.com/inward/record.url?scp=80052086156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052086156&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2010.09945.x

DO - 10.1111/j.1464-410X.2010.09945.x

M3 - Article

C2 - 21244609

AN - SCOPUS:80052086156

VL - 108

SP - 851

EP - 856

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 6

ER -